icon-    folder.gif   Conference Reports for NATAP  
 
  21st Conference on Retroviruses and
Opportunistic Infections
Boston, MA March 3 - 6, 2014
Back grey_arrow_rt.gif
 
 
 
HIV-1 Attachment Inhibitor Prodrug in Antiretroviral-Experienced Subjects: Week 24 Analysis
 
 
  AI438011: A Phase IIb, Randomized, Controlled, Partially-Blinded Trial to Investigate the Safety, Efficacy and Dose-response of BMS-663068 in Treatment-Experienced HIV-1-positive Subjects
 
Reported by Jules Levin
CROI 2014 March 3-6 Boston, MA
 
Lalezari J, Latiff GH, Brinson C, Echevarria J, Trevino-Perez S, Bogner JR, Stock D, Joshi SR, Hanna GJ, Lataillade M, for the AI438011 study team
 
CROI webcast:
http://www.croiwebcasts.org/console/player/22172?mediaType=slideVideo&
 

CROI1.gif

CROI2.gif

CROI3.gif

CROI4.gif

CROI5.gif

CROI6.gif

CROI7.gif

CROI8.gif